To verify the key role of NF-κB activation in AKI induced by cisplatin and Tim-3 deficiency, the inhibitors of NF-κB P65, PDTC (pyrrolidine dithiocarbamate) and TPCA1 were applied in cisplatin-induced AKI mice models. This evidence concerns the gene NFKB1 and acute kidney injury.